Why We Are Focused on Early-Stage Biotech
By Sal Daher, CFA From the sixty plus angel investments I made since the early 1990s most of the value has been created among the life science companies. That’s why I’m focusing my angel investing exclusively on life science startups. I expect the coming decade to see growing opportunities for angel investors to help academic …